In this study, researchers aimed to evaluate patterns of engagement with health-related content on social media among US adults both with and without chronic conditions.

This report presents the long-term follow-up results of JCOG1008, phase 2/3 trial comparing weekly cisplatin versus 3-weekly cisplatin for patients with postoperative high-risk locally advanced ...

The US Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer ...

A study of the Galleri multicancer early detection test did not meet its primary endpoint of reducing the detection of ...

New research suggests structured skin care improves the quality of life for patients with cancer by managing common treatment-related skin toxicities.

Public sarcoma awareness brought about by Sarcoma Awareness Month has led to research & treatment advances, & potentially fewer misdiagnoses.

A phase 2 study of ofirnoflast showed 67% overall hematologic improvement and 55% transfusion independence in ESA-refractory lower-risk MDS.

Backed by phase 3 PATINA trial data, Ibrance is the first and only CDK4/6 inhibitor available for HR+ metastatic disease across all HER2 patient profiles.

A federal watchdog has found that the 3 largest Medicare Advantage insurers had the highest rates of denying post-hospital care.

Investigators evaluated trends in incidence and mortality for patients with ovarian, fallopian tube, and peritoneal cancers who underwent oophorectomy.

Investigators assessed whether machine learning models provide accurate, individualized risk predictions for major 30-day postoperative complications following glossectomy.

Black populations have higher incidence and mortality for several cancers, including multiple myeloma, prostate cancer ...